Dimethyl Fumarate Alleviates Dextran Sulfate Sodium-Induced Colitis, through the Activation of Nrf2-Mediated Antioxidant and Anti-inflammatory Pathways

Oxidative stress and chronic inflammation play critical roles in the pathogenesis of ulcerative colitis (UC) and inflammatory bowel diseases (IBD). A previous study has demonstrated that dimethyl fumarate (DMF) protects mice from dextran sulfate sodium (DSS)-induced colitis via its potential antioxi...

Full description

Bibliographic Details
Published in:	Antioxidants
Main Authors:	Shiri Li, Chie Takasu, Hien Lau, Lourdes Robles, Kelly Vo, Ted Farzaneh, Nosratola D. Vaziri, Michael J. Stamos, Hirohito Ichii
Format:	Article
Language:	English
Published:	MDPI AG 2020-04-01
Subjects:	colitis Nrf2 dimethyl fumarate antioxidant anti-inflammation
Online Access:	https://www.mdpi.com/2076-3921/9/4/354

Similar Items

Prevention of Autoimmune Diabetes in NOD Mice by Dimethyl Fumarate
by: Shiri Li, et al.
Published: (2021-01-01)

Dimethyl Fumarate Ameliorates Doxorubicin-Induced Cardiotoxicity By Activating the Nrf2 Pathway
by: Xiaoliang Hu, et al.
Published: (2022-04-01)

Dimethyl Fumarate Triggers the Antioxidant Defense System in Human Retinal Endothelial Cells through Nrf2 Activation
by: Federico Manai, et al.
Published: (2022-09-01)

Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19
by: Cara A. Timpani, et al.
Published: (2020-12-01)

Nrf2-Independent Anti-Inflammatory Effects of Dimethyl Fumarate: Challenges and Prospects in Developing Electrophilic Nrf2 Activators for Neurodegenerative Diseases
by: Yasuhiko Izumi, et al.
Published: (2024-12-01)

The Challenge of Dimethyl Fumarate Repurposing in Eye Pathologies
by: Federico Manai, et al.
Published: (2022-12-01)

Dimethyl Fumarate as Potential Treatment for Alzheimer’s Disease: Rationale and Clinical Trial Design
by: Robert Sharkus, et al.
Published: (2023-05-01)

Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer’s disease
by: Ting Wang, et al.
Published: (2024-02-01)

Patients monitoring during treatment with Dimethyl fumarate (ORP-23)
by: Ali Yousefi Pour
Published: (2023-01-01)

Novel potential pharmacological applications of dimethyl fumarate—an overview and update
by: Giorgia Bresciani, et al.
Published: (2023-09-01)

Effects of dimethyl fumarate on neuroprotection and immunomodulation
by: Albrecht Philipp, et al.
Published: (2012-07-01)

Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study
by: Cédric O. Renaud, et al.
Published: (2022-05-01)

Repurposing dimethyl fumarate as an antiepileptogenic and disease-modifying treatment for drug-resistant epilepsy
by: Sereen Sandouka, et al.
Published: (2023-11-01)

Glucose-Impaired Corneal Re-Epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate
by: Giovanni Giurdanella, et al.
Published: (2021-05-01)

Dimethyl fumarate alleviates allergic asthma by strengthening the Nrf2 signaling pathway in regulatory T cells
by: Yanhong Cen, et al.
Published: (2024-04-01)

Lung-Targeted Delivery of Dimethyl Fumarate Promotes the Reversal of Age-Dependent Established Lung Fibrosis
by: Kosuke Kato, et al.
Published: (2022-02-01)

Short-term exposure to dimethyl fumarate (DMF) inhibits LPS-induced IκBζ expression in macrophages
by: Yong Zhang, et al.
Published: (2023-02-01)

Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study
by: Laura Gnesotto, et al.
Published: (2023-03-01)

Drug-Repurposing Strategy for Dimethyl Fumarate
by: Salvatore Giunta, et al.
Published: (2023-07-01)

Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
by: Stephanie Kourakis, et al.
Published: (2020-10-01)

A Bibliometric Evaluation of the Top 100 Cited Dimethyl Fumarate Articles
by: Francisco Javier García-Fernández, et al.
Published: (2021-02-01)

Repurposed Nrf2 activator dimethyl fumarate rescues muscle inflammation and fibrosis in an aggravated mdx mouse model of Duchenne muscular dystrophy
by: Stephanie Kourakis, et al.
Published: (2025-07-01)

Comparison of dimethyl fumarate and interferon outcomes in an MS cohort
by: Neda Sattarnezhad, et al.
Published: (2022-07-01)

The Age-Related Efficacy of Dimethyl Fumarate and Natalizumab in the Real-World Management of Multiple Sclerosis
by: Roberto De Masi, et al.
Published: (2021-01-01)

Repurposing dimethyl fumarate for gastric ulcer and ulcerative colitis: Evidence of local efficacy without systemic side effect
by: Vishal Patel, et al.
Published: (2022-12-01)

USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS
by: V. R. Mkrtchyan, et al.
Published: (2016-12-01)

Dimethyl Fumarate Protects Retinal Pigment Epithelium from Blue Light-Induced Oxidative Damage via the Nrf2 Pathway
by: Hideyuki Shimizu, et al.
Published: (2022-12-01)

Repurposing Dimethyl Fumarate for Cardiovascular Diseases: Pharmacological Effects, Molecular Mechanisms, and Therapeutic Promise
by: Shilu Deepa Thomas, et al.
Published: (2022-04-01)

Real-World Safety and Effectiveness of Dimethyl Fumarate in Hispanic or Latino Patients with Multiple Sclerosis: 3-Year Results from ESTEEM
by: Angel Chinea, et al.
Published: (2020-05-01)

Dimethyl fumarate confers neuroprotection by casein kinase 2 phosphorylation of Nrf2 in murine intracerebral hemorrhage
by: Loretta O. Iniaghe, et al.
Published: (2015-10-01)

Therapeutic Potential of Dimethyl Fumarate for the Treatment of High-Fat/High-Sucrose Diet-Induced Obesity
by: Helber da Maia Valenca, et al.
Published: (2024-12-01)

Dimethyl fumarate ameliorates erectile dysfunction in bilateral cavernous nerve injury rats by inhibiting oxidative stress and NLRP3 inflammasome-mediated pyroptosis of nerve via activation of Nrf2/HO-1 signaling pathway
by: Guoda Song, et al.
Published: (2023-12-01)

Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEM
by: Mitzi J. Williams, et al.
Published: (2020-05-01)

Elective First-Line Use of Dimethyl Fumarate in Psoriasis: Insights from an Italian Cohort
by: Alessandro Giunta, et al.
Published: (2025-10-01)

Exploring the Use of Dimethyl Fumarate as Microglia Modulator for Neurodegenerative Diseases Treatment
by: Maria Rosito, et al.
Published: (2020-08-01)

Aberrant regulation of the GSK‐3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy
by: Pablo Ranea‐Robles, et al.
Published: (2018-07-01)

NRF2 Activation Ameliorates Oxidative Stress and Improves Mitochondrial Function and Synaptic Plasticity, and in A53T α-Synuclein Hippocampal Neurons
by: Mikah S. Brandes, et al.
Published: (2021-12-01)

Transcriptome Analysis of Dimethyl Fumarate Inhibiting the Growth of <i>Aspergillus carbonarius</i>
by: Siruo Wang, et al.
Published: (2025-07-01)

Transcriptomic Analysis of Fumarate Compounds Identifies Unique Effects of Isosorbide Di-(Methyl Fumarate) on NRF2, NF-kappaB and IRF1 Pathway Genes
by: William R. Swindell, et al.
Published: (2022-04-01)

The Dimethyl Fumarate Experience: A Handy Drug With Broad Clinical Utility
by: Lorena Lorefice, et al.
Published: (2021-09-01)